Investment Rating - The report maintains a positive outlook on the non-bank financial sector, indicating an "Overweight" rating for the industry [4][48]. Core Insights - The report highlights a significant increase in new account openings, with 4.9158 million new accounts in January 2026, representing a year-over-year increase of 213% and a quarter-over-quarter increase of 89% [4]. - The report emphasizes the ongoing shift of funds from traditional banks to capital markets and non-bank financial institutions, driven by the expiration of 70 trillion yuan in one-year or longer deposits and a decline in net interest margins [4]. - The report discusses the need for China's financial sector to transition from being large to strong, focusing on mergers and acquisitions as a core growth engine for brokerages [4]. - The report notes that the international business landscape for brokerages is expanding due to the deepening process of RMB internationalization and the demand for cross-border wealth management and investment banking services [4]. - The report mentions that Ping An Group has increased its stake in China Life (H) multiple times, reflecting a strong confidence in the insurance sector [4][12]. Summary by Sections Market Review - The Shanghai Composite Index closed at 4,643.60 with a decline of 1.33%, while the non-bank index closed at 2,030.92 with a decline of 0.60% [8]. - The brokerage, insurance, and diversified financial indices reported declines of 0.65%, 0.71%, and an increase of 0.43%, respectively [8]. Non-Bank Industry News and Key Announcements - The report outlines regulatory updates regarding virtual currencies and asset tokenization, indicating a tightening of oversight in these areas [10]. - Ping An Group's recent acquisitions of shares in China Life (H) are detailed, showcasing a strategic investment approach [12]. - Huatai Securities plans to issue 10 billion HKD in zero-coupon convertible bonds to support overseas business development [14]. Investment Analysis Recommendations - The report suggests focusing on brokerages with strong comprehensive capabilities, recommending stocks such as Guotai Junan A+H, GF Securities A+H, and CITIC Securities A+H [4]. - For insurance, the report recommends China Life (H), New China Life, Ping An, China Pacific Insurance, and China Property & Casualty Insurance, highlighting the systemic value reassessment opportunities in the insurance sector [4].

Quantitative Models and Construction Methods 1. Model Name: Sentiment Model - **Model Construction Idea**: The sentiment model is designed to measure the strength of market sentiment using factors related to limit-up and limit-down stocks[14] - **Model Construction Process**: The model incorporates factors such as the proportion of net limit-up stocks, next-day returns of limit-down stocks, proportion of limit-up stocks, proportion of limit-down stocks, and high-frequency board-hitting returns. These factors are aggregated to generate a sentiment score, with a maximum score of 5. The sentiment score for the current period is 0[14][18] - **Model Evaluation**: The sentiment model indicates weak market sentiment, as reflected by the score of 0[14][18] 2. Model Name: Moving Average Strength Index - **Model Construction Idea**: This model evaluates the strength of market trends by calculating the moving average strength index based on secondary industry indices[14] - **Model Construction Process**: The moving average strength index is calculated using the performance of secondary industry indices. The current market score is 181, which corresponds to the 62.50th percentile since 2023[14] - **Model Evaluation**: The model suggests that the market still has significant downside potential[14] 3. Model Name: High-Frequency Capital Flow Model - **Model Construction Idea**: This model uses high-frequency capital flow trends to generate buy and sell signals for major broad-based indices[14] - **Model Construction Process**: The model tracks high-frequency capital flows and generates signals for indices such as CSI 300, CSI 500, CSI 1000, and CSI 2000. The signals for all indices are currently negative, indicating a bearish outlook[14][18] - **Model Evaluation**: The model shows a bearish signal across all major indices, reflecting weak market conditions[14][18] --- Model Backtesting Results 1. Sentiment Model - Sentiment score: 0 (out of 5)[14][18] 2. Moving Average Strength Index - Current score: 181 (62.50th percentile since 2023)[14] 3. High-Frequency Capital Flow Model - CSI 300: Negative signal - CSI 500: Negative signal - CSI 1000: Negative signal - CSI 2000: Negative signal[14][18] --- Quantitative Factors and Construction Methods 1. Factor Name: Factor Crowding Indicator - **Factor Construction Idea**: The factor crowding indicator measures the degree of crowding in specific factors, which can serve as a warning for factor underperformance[19] - **Factor Construction Process**: The indicator is calculated using four metrics: valuation spread, pairwise correlation, long-term return reversal, and factor volatility. These metrics are aggregated to produce a composite crowding score for each factor. For example: - Small-cap factor crowding score: 0.06 - Low-valuation factor crowding score: -0.31 - High-profitability factor crowding score: -0.01 - High-growth factor crowding score: 0.28[19][20] - **Factor Evaluation**: The crowding scores indicate varying levels of crowding across factors, with low-valuation and high-profitability factors showing negative scores, suggesting potential underperformance[19][20] --- Factor Backtesting Results 1. Factor Crowding Indicator - Small-cap factor crowding score: 0.06 - Low-valuation factor crowding score: -0.31 - High-profitability factor crowding score: -0.01 - High-growth factor crowding score: 0.28[19][20]

Core Viewpoint - The A-share market is experiencing a strong demand for financing from securities firms, leading to a significant increase in bond issuance, with a total approval amount exceeding 3,400 billion yuan for 2026 [5][10]. Group 1: Bond Issuance Trends - As of February 4, 2026, 12 securities firms have received approval for bond issuance, with a total amount reaching 3,400 billion yuan [5]. - In 2026, 46 securities firms have issued 120 domestic bonds, totaling over 3,168 billion yuan, with a net financing amount of 2,227.17 billion yuan [6][10]. - The bond issuance volume in 2026 has increased by over three times compared to the same period last year, driven by a low base from 2025 [6]. Group 2: Major Issuers - Leading securities firms such as Huatai Securities and Guotai Junan Securities have issued 350 billion yuan and 340 billion yuan in bonds, respectively, making them the largest issuers in 2026 [7]. - Other significant issuers include CITIC Securities, China Merchants Securities, and China Galaxy Securities, each exceeding 200 billion yuan in bond issuance [7][8]. Group 3: Purpose of Fundraising - The primary purpose of the bond issuance is to ensure liquidity and support business development, with many firms indicating that funds will be used for debt repayment and to supplement working capital [11][12]. - Specific allocations for capital-consuming businesses have been noted, with firms like Guotai Junan and CITIC Securities committing to limit the use of raised funds for such purposes to no more than 10% [13]. Group 4: H-share Financing - In addition to domestic bond issuance, major securities firms are also engaging in H-share refinancing, with Guangfa Securities planning to raise over 6 billion HKD through a combination of new H-share placements and convertible bonds [15]. - Huatai Securities announced a zero-coupon convertible bond issuance of 10 billion HKD, aimed at supporting overseas business development and enhancing operational capital [18].

2026年02月06日，瑞鹄模具披露接待调研公告，公司于02月06日接待睿远基金、国泰海通证券、开源证 券等3家机构调研。 瑞鹄模具（002997）最新股价为 34.77元，与前一交易日收盘价持平，总市值72.78亿元。从行业市盈率 来看，瑞鹄模具所处的汽车零部件行业滚动市盈率平均56.51倍，行业中值41.00倍，瑞鹄模具16.08倍排 名第10位。 天眼查资料显示，瑞鹄汽车模具股份有限公司成立于 2002年03月15日，是一家以从事专用设备制造业 为主的企业。截至2026年01月30日，瑞鹄模具股东户数24042户，较上次减少1358户，户均持股市值 30.27万元，户均持股数量0.87万股。 参与此次调研的睿远基金是一家以价值投资、研究驱动和长期投资风格为主的长期价值投资机构，聚焦 于权益投资和固定收益投资领域。截至目前，管理基金数量5只，其中睿远成长价值混合A最新单位净 值为1.9237，近一年增长66.96%。 调研情况显示，瑞鹄模具针对投资者关注的可转债募投项目进行了详细说明，公司表示三个募投项目分 别为"中高档乘用车大型精密覆盖件模具智能制造升级扩产项目"、"大型精密覆盖件模具关键材料智能 增材 ...

成熟商业化团队及分销网络构建，海外订单爆发式增长 精锋医疗于2017年5月在深圳创立，是中国自主研发手术机器人领域的深耕者，为中国首家、全球第二 家同时取得多孔腔镜手术机器人、单孔腔镜手术机器人及自然腔道手术机器人注册审批的公司，已构建 多孔+单孔+远程系统的"三合一"外科手术解决方案。公司全球首创的单多孔手术机器人超级系统 MSP2000已于2025年10月获得CE证，为全球手术机器人的技术演进与临床应用提供创新范本。 24年国内厂商销量第一，持续落地中国顶级医院圈层 自精锋多孔腔镜手术机器人于2022年12月商业化以来，于2024年在中国售出了20台精锋多孔腔镜手术机 器人，在国内手术机器人制造商中排名第一，临床应用范围已覆盖全国30个省份，超过220家医院，包 括国内顶尖三甲医院乃至多个省份的县域基层医院，实现了"省-市-县"三级医院网络的全覆盖。伴随国 内销量大幅增长以及海外的商业化，公司总收入由2023年的0.48亿元增加至2024年的1.6亿元，并由 2024H1的0.30亿元增加至2025H1的1.49亿元。 国泰海通证券发布研报称，首次覆盖精锋医疗-B(02675)给予评级为"增持"。预测公司 ...

自精锋多孔腔镜手术机器人于2022年12月商业化以来，于2024年在中国售出了20台精锋多孔腔镜手术机 器人，在国内手术机器人制造商中排名第一，临床应用范围已覆盖全国30个省份，超过220家医院，包 括国内顶尖三甲医院乃至多个省份的县域基层医院，实现了"省-市-县"三级医院网络的全覆盖。伴随国 内销量大幅增长以及海外的商业化，公司总收入由2023年的0.48亿元增加至2024年的1.6亿元，并由 2024H1的0.30亿元增加至2025H1的1.49亿元。 智通财经APP获悉，国泰海通证券发布研报称，首次覆盖精锋医疗-B(02675)给予评级为"增持"。预测公 司2025-2027年的收入分别为4.32、8.11、12.36亿元，参考可比公司，考虑公司产品布局领先，海外进 展迅速，给予公司2026年35XPS，对应目标价73.20元/79.57港元（汇率为1港元=0.92人民币）。 国泰海通证券主要观点如下： 国产手术机器人引领者，持续革新推动技术进步 精锋医疗于2017年5月在深圳创立，是中国自主研发手术机器人领域的深耕者，为中国首家、全球第二 家同时取得多孔腔镜手术机器人、单孔腔镜手术机器人及自然腔道手术 ...

2026年02月06日，锐明技术披露接待调研公告，公司于02月03日至02月05日接待睿远基金管理有限公 司、国泰海通证券股份有限公司、东方证券股份有限公司、招商证券股份有限公司、合众资产管理股份 有限公司、大家资产管理有限责任公司等68家机构调研。 天眼查资料显示，深圳市锐明技术股份有限公司成立于 2002年09月03日，是一家以从事专业技术服务 业为主的企业。截至2025年09月30日，锐明技术股东户数26704户，较上次增加6611户，户均持股市值 49.29万元，户均持股数量0.68万股。 参与此次调研的睿远基金是一家以价值投资、研究驱动和长期投资风格为主的长期价值投资机构，聚焦 于权益投资和固定收益投资领域。截至目前，管理基金数量5只，其中睿远成长价值混合A最新单位净 值为1.9237，近一年增长66.96%。 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 财经频道更多独家策划、专家专栏，免费查阅>> 责任编辑：栎树 锐明技术（002970）股价报72.87元，较前一交易日收盘价上涨0.13元，涨幅为0.18%，总市值131.63亿 元。从行业市盈率来看 ...

国泰海通证券主要观点如下： 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 国泰海通证券发布研报称，在AI与脑机接口深度融合趋势及十五五规划政策加持下，技术迭代与场景 落地成为行业核心驱动力，AI融合赋能与政策资本加持下，脑机接口多技术路线并行推进，场景落地 加速开启商业化增长周期。看好全链条布局、AI赋能突出及临床场景绑定紧密的企业。 应用场景多点突破，商业化落地开启长期增长空间，头部企业多维布局构筑优势 风险提示：技术研发与商业化落地不及预期、政策监管与伦理合规风险、行业竞争加剧与核心部件依赖 风险。 脑机接口凭借双向信息传输能力构建人机协同通路，形成多技术路线并行发展格局 医疗健康是当前最确定的基本盘，已在听力障碍、震颤治疗、运动康复等领域实现产业化落地，国内多 家医院开启临床布局，医保支付体系完善进一步打通落地路径。消费、工业等场景加速拓展，消费端依 托非侵入式技术覆盖残障群体与健康人群需求，政策支持下有望成为高成长性新赛道；工业端聚焦高 危、高精度作业需求，处于试验验证向商业化落地过渡阶段。头部企业通过全链条研发、产学研合作、 多场景布局构建竞争壁垒，分别在非侵入式技术应用 ...

国泰海通证券发布研报称，政策落地、全球并购回暖及积极临床数据共同提振创新药行业风险偏好。 2026年，肿瘤领域PD-1/VEGF双抗和Pan-RAS疗法迎来关键数据验证；减重代谢市场关注自费市场拓展 及小核酸技术升级；自免领域聚焦新一代抗体平台POC数据；中枢神经系统(CNS)领域则围绕Aβ单抗治 疗前移与递送技术突破。 国泰海通证券主要观点如下： 自免：MNC大单品集中度风险凸显，2026年POC数据读出带来结构性机会 MNC自免业务对少数重磅单品依赖度较高，专利周期与竞争加剧背景下的收入集中风险逐步显现。增 量机会主要来自两条路径：其一，新一代抗体平台(双抗/多抗、B细胞耗竭等)将在2026年迎来密集POC 数据读出，或催生新一轮BD与资产重估；其二，口服化趋势逐步清晰，自免疾病长期用药属性决定了 口服剂型在依从性与差异化竞争上的天然优势，BTK、TYK2/JAK、口服PROTAC、口服环肽、PDE4等 多技术路线值得持续跟踪。 CNS：核心主线是Aβ单抗治疗前移，跨BBB技术放大长期空间 CNS领域的核心投资主线仍聚焦于Aβ单抗治疗从早期症状人群向临床前(preclinic alAD)前移，礼来 Don ...

登录新浪财经APP 搜索【信披】查看更多考评等级 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 证券代码：601211 证券简称：国泰海通 公告编号：2026-006 国泰海通证券股份有限公司 关于A股限制性股票激励计划预留授予部分第三个限售期解除限售暨上市公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次股票上市类型为股权激励股份；股票认购方式为网下，上市股数为2,916,898股。 ● 本次股票上市流通总数为2,916,898股。 ● 本次股票上市流通日期为2026年2月12日。 ● 公司高级管理人员自愿性承诺：基于对公司未来发展前景的信心及对公司价值的认可，在本次公司A 股限制性股票解除限售上市流通之日起12个月内，不以任何方式减持公司A股股票，亦不会要求公司回 购所持公司A股股票。 国泰海通证券股份有限公司（曾用名：国泰君安证券股份有限公司，以下简称国泰海通或本公司或公 司）于2026年1月20日召开第七届董事会第十次会议（临时会议），审议通过了《关于公司A股 ...